ArticleOphthalmology and therapy2025
Early Clinical Results of a Newly Developed Continuous Range of Vision Intraocular Lens.
Article in Ophthalmology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Comparative Study of the Visual Outcomes of Two Common Diffractive Trifocal Intraocular Lenses in a Matched Cohort.Cureus · 2026Article
- Clinical Outcomes Following Bilateral Implantation of TECNIS Odyssey Intraocular Lenses in Japanese Eyes.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical Outcomes Following Bilateral Implantation of a Next-Generation Intraocular Lens in Patients with Primary Open Angle Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Comparison of Visual Performance and Patient Satisfaction Between Two Trifocal Intraocular Lenses: A Prospective, Paired-Eye Comparative Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA newly developed diffractive continuous range of vision (CRV) intraocular lens (IOL) (TECNIS Odyssey) was introduced to reduce photic phenomena compared to the previous model (Synergy). This brief report is the first to evaluate the early postoperative outcomes of the new CRV IOL in a Japanese population.
methodsThis retrospective review included 50 eyes of 25 patients with cataracts who underwent bilateral implantation of modified CRV IOLs (models DNR00V and DRT150-375, TECNIS Odyssey). Clinical records of the patients were obtained. One month postoperative assessments included monocular and binocular uncorrected visual acuity (UCVA) and distance-corrected visual acuity (DCVA) at 5 m, 60 cm, and 40 cm. Additionally, binocular photopic contrast sensitivity, defocus curve, spectacle independence, incidence of photic phenomena, and overall patient satisfaction were evaluated.
resultsThe mean patient age was 65.2 ± 8.4 years, with a mean IOL power of 17.4 ± 4.7 D. Postoperative binocular UCVA/DCVA (logMAR) at 5 m, 60 cm, and 40 cm was - 0.18 ± 0.06/ - 0.21 ± 0.06, - 0.01 ± 0.08/ - 0.01 ± 0.08, and 0.00 ± 0.08/0.00 ± 0.07, respectively. Contrast sensitivity remained within normal limits at all spatial frequencies. The binocular defocus curve showed DCVA of 0.0 logMAR or better across a range from + 0.5 to - 2.0 D. Spectacle independence was achieved in 64% of patients, whereas the remainder required reading glasses. Reports of glare and starburst were minimal (84% and 76% of patients reported none or minimal, respectively), whereas 52% experienced moderate to severe halos. Overall, 96% of the patients were satisfied or very satisfied with their distance and intermediate vision, and 68% were satisfied with their near vision.
conclusionsThe new diffractive CRV IOL offers simultaneous vision across a broad range, with improved tolerance to photic phenomena, while maintaining comparable visual acuity at far, intermediate, and near distances compared to the previous model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.